메뉴 건너뛰기




Volumn 65, Issue 1, 2011, Pages 55-63

An open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorder

Author keywords

atomoxetine; attention deficit hyperactivity disorder; Japanese adult; safety; tolerability

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATOMOXETINE; CHLORIDE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; THYROTROPIN; UREA; URIC ACID;

EID: 79251584016     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2010.02159.x     Document Type: Article
Times cited : (20)

References (22)
  • 1
    • 0036920908 scopus 로고    scopus 로고
    • Management of ADHD in adults
    • Adler LA, Chua HC,. Management of ADHD in adults. J. Clin. Psychiatry 2002; 63 (Suppl 12): 29-33.
    • (2002) J. Clin. Psychiatry , vol.63 , Issue.SUPPL. 12 , pp. 29-33
    • Adler, L.A.1    Chua, H.C.2
  • 3
    • 33749493283 scopus 로고    scopus 로고
    • Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder
    • Biederman J, Petty C, Fried R, et al. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am. J. Psychiatry 2006; 163: 1730-1738.
    • (2006) Am. J. Psychiatry , vol.163 , pp. 1730-1738
    • Biederman, J.1    Petty, C.2    Fried, R.3
  • 5
    • 0034237269 scopus 로고    scopus 로고
    • Attention-deficit/hyperactivity disorder in adults: An overview
    • Faraone SV, Biederman J, Spencer T, et al. Attention-deficit/ hyperactivity disorder in adults: An overview. Biol. Psychiatry 2000; 48: 9-20.
    • (2000) Biol. Psychiatry , vol.48 , pp. 9-20
    • Faraone, S.V.1    Biederman, J.2    Spencer, T.3
  • 6
    • 1842477104 scopus 로고    scopus 로고
    • Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder
    • Adler L, Cohen J,. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr. Clin. North. Am. 2004; 7: 187-201.
    • (2004) Psychiatr. Clin. North. Am. , vol.7 , pp. 187-201
    • Adler, L.1    Cohen, J.2
  • 7
    • 79251549523 scopus 로고    scopus 로고
    • Attention-deficit hyperactivity disorder in adulthood: The current state and problems
    • Tanaka Y,. Attention-deficit hyperactivity disorder in adulthood: the current state and problems. J. Psychiatr. Treat. 2004; 19: 415-424.
    • (2004) J. Psychiatr. Treat. , vol.19 , pp. 415-424
    • Tanaka, Y.1
  • 8
    • 2142703728 scopus 로고    scopus 로고
    • Diagnosis and treatment of ADHD in adults in primary care
    • Montano B,. Diagnosis and treatment of ADHD in adults in primary care. J. Clin. Psychiatry 2004; 65: 18-21.
    • (2004) J. Clin. Psychiatry , vol.65 , pp. 18-21
    • Montano, B.1
  • 9
    • 0036848458 scopus 로고    scopus 로고
    • Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder
    • Bymaster FP, Katner JS, Nelson DL, et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002; 27: 699-711.
    • (2002) Neuropsychopharmacology , vol.27 , pp. 699-711
    • Bymaster, F.P.1    Katner, J.S.2    Nelson, D.L.3
  • 10
    • 0036644683 scopus 로고    scopus 로고
    • Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users
    • Heil SH, Holmes HW, Bickel WK, et al. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend. 2002; 67: 149-156.
    • (2002) Drug Alcohol Depend. , vol.67 , pp. 149-156
    • Heil, S.H.1    Holmes, H.W.2    Bickel, W.K.3
  • 11
    • 0036181544 scopus 로고    scopus 로고
    • Identification of the human cytochromes P450 responsible for atomoxetine metabolism
    • Ring BJ, Gillespie JS, Eckstein JA, Wrighton SA,. Identification of the human cytochromes P450 responsible for atomoxetine metabolism. Drug Metab. Dispos. 2002; 30: 319-323.
    • (2002) Drug Metab. Dispos. , vol.30 , pp. 319-323
    • Ring, B.J.1    Gillespie, J.S.2    Eckstein, J.A.3    Wrighton, S.A.4
  • 12
    • 0013499111 scopus 로고    scopus 로고
    • Disposition and metabolic fate of atomoxetine hydrochloride: The role of CYP2D6 in human disposition and metabolism
    • Sauer JM, Ponsler GD, Mattiuz EL, et al. Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism. Drug Metab. Dispos. 2003; 31: 98-107.
    • (2003) Drug Metab. Dispos. , vol.31 , pp. 98-107
    • Sauer, J.M.1    Ponsler, G.D.2    Mattiuz, E.L.3
  • 13
    • 85006639536 scopus 로고    scopus 로고
    • Bioinformatics research on inter-racial difference in drug metabolism I. Analysis on frequencies of mutant alleles and poor metabolizers on CYP2D6 and CYP2C19
    • Shimizu T, Ochiai H, Asell F, et al. Bioinformatics research on inter-racial difference in drug metabolism I. Analysis on frequencies of mutant alleles and poor metabolizers on CYP2D6 and CYP2C19. Drug Metab. Pharmacokinet. 2003; 18: 48-70.
    • (2003) Drug Metab. Pharmacokinet. , vol.18 , pp. 48-70
    • Shimizu, T.1    Ochiai, H.2    Asell, F.3
  • 14
    • 69549118772 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit/hyperactivity disorder
    • Takahashi M, Takita Y, Yamazaki K, et al. A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 2009; 19: 341-350.
    • (2009) J. Child Adolesc. Psychopharmacol. , vol.19 , pp. 341-350
    • Takahashi, M.1    Takita, Y.2    Yamazaki, K.3
  • 15
    • 12244298956 scopus 로고    scopus 로고
    • Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies
    • Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biol. Psychiatry 2003; 53: 112-120.
    • (2003) Biol. Psychiatry , vol.53 , pp. 112-120
    • Michelson, D.1    Adler, L.2    Spencer, T.3
  • 18
    • 79251548312 scopus 로고    scopus 로고
    • Reliability and validity of the Japanese version of CAARS-Screening version (CAARS-SV), Adult ADHD symptom rating scale
    • Takahashi M, Takita Y, Ichikawa H, et al. Reliability and validity of the Japanese version of CAARS-Screening version (CAARS-SV), Adult ADHD symptom rating scale. Clin. Psychiatry 2011; 53: 23-34.
    • (2011) Clin. Psychiatry , vol.53 , pp. 23-34
    • Takahashi, M.1    Takita, Y.2    Ichikawa, H.3
  • 20
    • 0000306728 scopus 로고
    • Clinical global impression scale
    • National Institute of Mental Health.
    • National Institute of Mental Health. Clinical global impression scale. Psychopharmacol. Bull. 1985; 21: 839-943.
    • (1985) Psychopharmacol. Bull. , vol.21 , pp. 839-943
  • 21
    • 33745066143 scopus 로고    scopus 로고
    • Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD
    • Adler L, Dietrich A, Reimherr FW, et al. Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD. Ann. Clin. Psychiatry 2006; 18: 107-113.
    • (2006) Ann. Clin. Psychiatry , vol.18 , pp. 107-113
    • Adler, L.1    Dietrich, A.2    Reimherr, F.W.3
  • 22
    • 62649135353 scopus 로고    scopus 로고
    • Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: A 6-month, double-blind trial
    • Adler LA, Spencer T, Brown TE, et al. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J. Clin. Psychopharmacol. 2009; 29: 44-50.
    • (2009) J. Clin. Psychopharmacol. , vol.29 , pp. 44-50
    • Adler, L.A.1    Spencer, T.2    Brown, T.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.